Damiano Rizzoni: Influence Statistics

Damiano Rizzoni

Damiano Rizzoni

Division of Medicine, Department of Clinical and Experimental Sciences, Spedali Civili di Brescia, 25121 Montichiari, BS, Italy | Department of Clinical and Experimental ...

Damiano Rizzoni: Expert Impact

Concepts for which Damiano Rizzoni has direct influence: Blood pressure , Hypertensive patients , Primary aldosteronism , Structural alterations , Microvascular structure , Small resistance , Antihypertensive treatment .

Damiano Rizzoni: KOL impact

Concepts related to the work of other authors for which for which Damiano Rizzoni has influence: Blood pressure , Primary aldosteronism , Endothelial dysfunction , Arterial stiffness , Hypertensive patients , Essential hypertension , Ventricular hypertrophy .

KOL Resume for Damiano Rizzoni

Year
2022

Division of Medicine, Department of Clinical and Experimental Sciences, Spedali Civili di Brescia, 25121 Montichiari, BS, Italy

General Medicine, Hospital of Montichiari, Montichiari (BS), ASST Spedali Civili, Brescia, ITALY

2021

Division of Medicine, Covid-19 Unit M, Spedali Civili di Brescia

2020

Division of Medicine, Covid-19 Unit M, Spedali Civili di Brescia, Montichiari, Brescia, Italy

Department of Clinical & Experimental Sciences, University of Brescia.

Clinica Medica, Dipartimento di Scienze Cliniche e Sperimentali, Università degli Studi di Brescia

2019

From the Department of Clinical and Experimental Sciences, University of Brescia, 2a Medicina ASST Spedali Civili di Brescia, Italy.

2018

and Istituto Clinico Città di Brescia, Division of Medicine, Italy (D.R.).

2017

Clinica Medica, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy;

2016

a Internal Medicine, Department of Clinical and Experimental Sciences , University of Brescia , Brescia , Italy.

2015

Clinica Medica, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, ITALY

2014

From Clinica Medica, Department of Clinical and Experimental Sciences (M.S., C.A.R., A.P., C.A., D.R., E.A.R., M.L.M.), and Ophthalmology (A.C., S.D., F.S.), University of Brescia, Brescia, Italy.

Clinica Medica, Department of Clinical and Experimental Sciences, c/o 2a Medicina Spedali Civili di Brescia, University of Brescia, Piazza Spedali Civili 1, 25100, Brescia, Italy

2013

Clinica Medica, Department of Clinical and Experimental Sciences, University of Brescia, c/o 2a Medicina, Spedali Civili di Brescia, 25100, Brescia, Italy

2012

Clinica Medica

Department of Internal Medicine, University of Brescia, Brescia, Italy

2011

Università Di Brescia, Dipartimento Di Scienze Medicihe E Chirurgiche, Brescia‐Italy, Chair of Ophthalmology, University of Brescia, Brescia‐Italy, Chair of Ophthalmology, University of Molise, Campobasso‐Italy, Chair of Ophthalmology, University of Ferrara, Ferrara‐Italy, Chair of General Surgery, Department of Medical and Surgical Sciences, University of Brescia, Brescia‐Italy

Chair of Internal Medicine, ClinicaMedica, Department of Medical and Surgical Sciences, University of Brescia, c/o 2a Medicina Spedali Civili di Brescia Piazza Spedali Civili 1, 25100, Brescia, Italy

2010

From the Clinica Medica, Department of Medical and Surgical Sciences (E.P., C.D.C., S.P., G.E.M.B., C.P., A.P., D.A., D.R., E.A.R.), and Department of Biomedical Sciences and Biotechnology (R.R., F.B., L.F.R.), University of Brescia, Brescia, Italy.

Clinica Medica, Department of Medical and Surgical Sciences, University of Brescia c/o 2a Medicina Spedali Civili di Brescia Piazza Spedali Civili 1 25100 Brescia, Italy

2009

Department of Medical and Surgical Sciences, Clinica Medica, University of Brescia, Brescia, Italy

2008

Clinica Medica, Department of Medical and Surgical Sciences, University of Brescia, Chair of Internal Medicine, II Medicina, Spedali Civili, 25100, Brescia, Italy

2007

DMCS-Clinica Medica 4, University Hospital, Padova, Italy

Arthur C. Guyton Professor and Chair, Department of Physiology and Biophysics

Associate Vice Chancellor for Research, University of Mississippi Medical Center, Jackson, Mississippi, USA

Professor of Cardiovascular Medicine, Director, Haemostasis, Thrombosis, and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, United Kingdom

2006

For a list of author affiliations, please see the Appendix

Department of Medical and Surgical Sciences, University of Brescia, II Medicina Spedali Civili di Brescia, Piazza Spedali Civili 1, 25100, Brescia, Italy

Prominent publications by Damiano Rizzoni

KOL-Index: 16018 . We investigated the role of angiotensin II (Ang II) and endothelin-1 (ET-1) in transgenic (mREN2)27 rats, a model of the monogenic renin-dependent form of severe hypertension and cardiovascular disease. Four-week-old heterozygous male transgenic (mREN2)27 rats (n=24) were matched according to body weight (BW) and blood pressure (BP) and randomly allocated to receive a placebo (group P), ...
Known for Endothelin Receptor | Cardiovascular Disease | Type 1 | Antihypertensive Agents
KOL-Index: 15960 . The aims of this study were to determine the prevalence of structural changes in the carotid arteries and heart and the correlation between these changes and the commonly recognized cardiovascular risk factors in the general population. Structural changes in the carotid arteries were defined as the intima-media thickness of the artery measured by B-mode ultrasound. Changes in the heart ...
Known for Vobarno Study | Blood Pressure | Northern Italy | Carotid Arteries
KOL-Index: 14522 . BACKGROUND: Structural alterations of subcutaneous small resistance arteries, as indicated by an increased media-to-lumen ratio, are frequently present in hypertensive and/or diabetic patients, and may represent the earliest alteration observed. Furthermore, media-to-lumen ratio of small arteries evaluated by micromyography has a strong prognostic significance; however, its extensive ...
Known for Retinal Arterioles | Lumen Ratio | Small Arteries | Laser Doppler Flowmetry
KOL-Index: 14410 . A hyperinflammatory syndrome (HIS) may cause a life-threatening acute respiratory distress syndrome (ARDS) in patients with COVID-19 pneumonia. A prospective series of 100 consecutive patients admitted to the Spedali Civili University Hospital in Brescia (Italy) between March 9th and March 20th with confirmed COVID-19 pneumonia and ARDS requiring ventilatory support was analyzed to ...
Known for Hyperinflammatory Syndrome | Acute Respiratory Failure | Covid19 Pneumonia | Ards Patients
KOL-Index: 13963 . BACKGROUND: It has been previously demonstrated that dihydropyridine calcium channel blockers may possess antioxidant properties and might improve vascular structure. Combination treatment with an angiotensin-converting enzyme inhibitor may have additional advantages, compared with a thiazide diuretic, in this regard. The aim of the present study was, therefore, to investigate the effects ...
Known for Microvascular Structure | Antihypertensive Treatment | Oxidative Stress | Lercanidipine Enalapril
KOL-Index: 12480 . BACKGROUND: It is not presently known whether non-insulin-dependent diabetes mellitus (NIDDM) is associated with the presence of structural alterations in small arteries or whether the combination of hypertension and NIDDM may have an additive effect on endothelial dysfunction. Therefore, we investigated subcutaneous small arteries in 12 normotensive subjects (NT group), 18 patients with ...
Known for Small Arteries | Structural Alterations | Eh Niddm | Diabetes Mellitus
KOL-Index: 12444 . It was previously observed that a significant regression of structural alterations and endothelial dysfunction in mesenteric small arteries of spontaneously hypertensive rats (SHRs) may be obtained after therapy with angiotensin-converting enzyme (ACE) inhibitors. It is not clear whether angiotensin II-type 1 receptor blockers may share this properties. We evaluated the effects of the ACE ...
Known for Endothelial Function | Candesartan Cilexetil | Structural Alterations | Resistance Arteries
KOL-Index: 12084 . Several factors have been proposed to explain the high death rate of the coronavirus disease 2019 (COVID-19) outbreak, including hypertension and hypertension-related treatment with Renin Angiotensin System inhibitors. Also, age and multimorbidity might be confounders. No sufficient data are available to demonstrate their independent role. We designed a cross-sectional, observational, ...
Known for Italian Society | Charlson Comorbidity | Patients Hypertension | Age Multimorbidity
KOL-Index: 12001 . OBJECTIVE: Arterial hypertension is frequently associated with the presence of endothelial dysfunction in human subcutaneous small resistance arteries, as evaluated by responses to acetylcholine or bradykinin; however it is not known whether patients with diabetes mellitus show similar alterations. Therefore, we have investigated endothelial function in subcutaneous arteries of ...
Known for Endothelial Dysfunction | Diabetes Mellitus | Eh Niddm | Resistance Arteries
KOL-Index: 11954 . Left ventricular (LV) mass and geometry predict risk for cardiovascular events in hypertension. Regression of LV hypertrophy (LVH) may imply an important prognostic significance. The relation between changes in LV geometry during antihypertensive treatment and subsequent prognosis has not yet been determined. A total of 436 prospectively identified uncomplicated hypertensive subjects with ...
Known for Concentric Geometry | Hypertensive Patients | Cardiovascular Prognosis | Lv Mass
KOL-Index: 11806 . Structural alterations of small arteries in patients with essential hypertension are characterized by inward eutrophic remodeling. However, small arteries in patients with secondary hypertension, as well as in experimental models of hypertension with high circulating renin, are characterized by inward hypertrophic remodeling, which is characterized by smooth muscle cell hypertrophy in ...
Known for Small Arteries | Renovascular Hypertension | Primary Aldosteronism | Animal Models
KOL-Index: 11683 . It has been proposed that several neurohumoral factors may be involved in the genesis of vascular structural changes (remodeling or hypertrophy) frequently observed in essential hypertension. Therefore, in this study we investigated vascular structural alterations of subcutaneous small resistance arteries in patients with secondary forms of hypertension. The study included 70 participants: ...
Known for Secondary Hypertension | Vascular Hypertrophy | Patients Pheochromocytoma | Endothelial Function
KOL-Index: 11471 . OBJECTIVE: To investigate the effects of the dual angiotensin-converting enzyme (ACE) + neutral endopeptidase (NEP) inhibitor, MDL-100,240 (MDL), on hypertension and cardiovascular damage in male heterozygous transgenic Ren2 rats. METHODS: Blood-pressure-matched 5-week-old transgenic rats were allocated to receive a placebo, MDL (40 mg/kg body weight) or ramipril (5 mg/kg body weight) for ...
Known for Blood Pressure | Dual Ace | Ramipril Rats | 4 Weeks

The smoothness index


[ PUBLICATION ]
KOL-Index: 11441 . OBJECTIVE: To introduce a new method, the smoothness index, for assessing the homogeneity of 24 h blood pressure reduction by antihypertensive treatment and to compare it with the trough : peak ratio; and to assess the ability of both indices to predict a reduction in the left ventricular mass index induced by treatment. PATIENTS AND METHODS: In 174 patients with essential hypertension and ...
Known for Peak Ratio | Pressure Blood | 3 Months Treatment | Ventricular Mass

Key People For Blood Pressure

Top KOLs in the world
#1
Giuseppe Mancia
blood pressure heart rate metabolic syndrome
#2
Suzanne Oparil
blood pressure resistant hypertension cardiovascular disease
#3
Gianfranco Gianfranco
blood pressure heart failure european society
#4
Alberto Zanchetti
blood pressure hypertensive patients essential hypertension
#5
Jackson T Wright
blood pressure african americans kidney disease
#6
Jan Albert Staessen
blood pressure systolic hypertension renal denervation

Division of Medicine, Department of Clinical and Experimental Sciences, Spedali Civili di Brescia, 25121 Montichiari, BS, Italy | Department of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, 25121 Brescia, BS, Italy;, clau